Physician

Ahmad Rehmani

According to 2025 Medicare claims, Ahmad Rehmani (NPI: 1801275185) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is EYE CENTERS OF AMERICA, LLC (NPI: 1649563636; TIN: 273654710) and primary practice location at 07470-3112.

Rehmani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 786 traditional Medicare patients, billed 373,520 HCPCS/CPT codes, and received $2,288,966 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,037 prescription claims across 347 beneficiaries totaling $55,258 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $387. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,954 to $55,258. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.3M2021 Medicare payment: $3,065 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $155,590 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,133,365 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,288,966 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20212452$3,065
20222751,331$155,590
202367617,706$1,133,365
2024786373,520$2,288,966

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$36K$73K2015 Drug cost: $1,954 (USD; Tot_Drug_Cst)2017 Drug cost: $490 (USD; Tot_Drug_Cst)2018 Drug cost: $9,015 (USD; Tot_Drug_Cst)2019 Drug cost: $6,162 (USD; Tot_Drug_Cst)2020 Drug cost: $2,704 (USD; Tot_Drug_Cst)2021 Drug cost: $2,810 (USD; Tot_Drug_Cst)2022 Drug cost: $11,044 (USD; Tot_Drug_Cst)2023 Drug cost: $72,508 (USD; Tot_Drug_Cst)2024 Drug cost: $55,258 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R64$1,954
2016N/RN/RN/R
2017N/R16$490
20182093$9,015
20191760$6,162
20202050$2,704
20213482$2,810
202275166$11,044
2023279876$72,508
20243471,037$55,258

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system6401,656$104
67028Injection of drug into eye2471,286$97
92134Imaging of retina7051,853$34
92201Extended exam of the back part of the eye with retinal drawing282379$20
92202Extended exam of the back part of the eye with optic nerve drawing390669$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate34314,666$18,075
ProlensaBromfenac Sodium19523$6,501
Ketorolac TromethamineKetorolac Tromethamine1204,257$4,364
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol261,325$2,954
Brimonidine TartrateBrimonidine Tartrate281,566$1,583

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$387Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmad Rehmani?

Tedicare shows public-source Medicare data for Ahmad Rehmani (NPI 1801275185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Rehmani have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmad Rehmani?

Ahmad Rehmani is linked to EYE CENTERS OF AMERICA, LLC (billing NPI 1649563636) in the available physician profile data.

Does Ahmad Rehmani have Open Payments data?

Ahmad Rehmani has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.